APOTHEEK TEN VOORDE
ActiveSummary
APOTHEEK TEN VOORDE has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €220,710 and a net result of €52,994. Equity has been growing by about 5.7% per year since 2018. Its solvency ranks better than 79% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 04-03-2009 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.177.884.481 1800 Vilvoorde, since 01-04-2009
- Financial year end
- 31 December
- Peppol
- Reachable since 29-09-2025
Board and ownership
- JAPPENS BVDirector · since 01-04-2011
- JAPPENS99%2025 annual accounts of JAPPENS
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €55,584
- ▼ 23.0%
- Turnover
- ≈ €270,000
- estimated
- Profit
- €52,994
- ▼ 34.1%
- Equity
- €220,710
- ▲ 1.4%
- Total assets
- €332,680
- ▼ 0.1%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.92, cash €122,130Founded in 2009Equity €220,710 (66.3% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 78% of them on solvency, 85% on liquidity, 84% on profitability and 44% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 15 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 8 profitable years in a rowprofit 2025: €52,994 8 years View
Recent changes
- · Gazette deed Change of role: JAPPENS Joost Dirk Michiel, from manager to directorPermanent representative: JAPPENS Joost Dirk Michiel · “Het administratief en commercieel beheer van één of meer apotheken uitgebaat onder het wetenschappelijk…” (deed in Dutch) · Director discharge: JAPPENS
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK TEN VOORDE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €267,000 and €486,000, founded between 2003 and 2011.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK TEN VOORDE Vilvoorde | €332,680 | €55,584 |
| PHARMA DMS Roeselare | €355,287 | €71,811 |
| APOTHEEK DE MEESTER Turnhout | €485,866 | €58,996 |
| PHARMACIE BODEN Seraing | €267,278 | €87,365 |
| DECAPHARMA Knokke-Heist | €291,134 | €65,566 |
| TANNHAUSER PHARAESCOS Koekelberg | €292,153 | €30,406 |
| Apotheek Ellen Cogge Gent | €465,443 | €76,828 |
Key facts about APOTHEEK TEN VOORDE
- What is the company number of APOTHEEK TEN VOORDE?
- The company number of APOTHEEK TEN VOORDE is 0810.185.174. The VAT number is the same number with BE in front: BE 0810.185.174.
- Where is APOTHEEK TEN VOORDE based?
- The registered office is at Steenstraat 96, 1800 Vilvoorde.Company details
- What does APOTHEEK TEN VOORDE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK TEN VOORDE?
- The legal form of APOTHEEK TEN VOORDE is Private limited company (BV).
- When was APOTHEEK TEN VOORDE founded?
- APOTHEEK TEN VOORDE was founded on 04-03-2009.
- Is APOTHEEK TEN VOORDE still active?
- Yes, APOTHEEK TEN VOORDE is an active enterprise in the KBO register.
- What is the turnover of APOTHEEK TEN VOORDE?
- The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €55,584 and 73 comparable companies (NACE 477). It probably lies between €130,000 and €390,000.Financials
- Is APOTHEEK TEN VOORDE profitable?
- In financial year 2025, APOTHEEK TEN VOORDE made a profit of €52,994.
- Where can I find the annual accounts of APOTHEEK TEN VOORDE?
- APOTHEEK TEN VOORDE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK TEN VOORDE due?
- APOTHEEK TEN VOORDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.